Screener
The Cooper Companies, Inc. COO Toric and multifocal — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Cooper Companies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.
- Filed
- Jun 5, 2026, 4:47 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-041305
| Periods Ended April 30, / (In millions) | Three Months / 2026 | Three Months / 2025 | Six Months / 2026 | Six Months / 2025 |
|---|---|---|---|---|
| CooperVision net sales by category: | ||||
| Toric and multifocal | $364.9 | $328.4 | $716.1 | $647.8 |
| Sphere, other | 358.6 | 341.2 | 702.5 | 667.9 |
| Total CooperVision net sales | $723.5 | $669.6 | $1,418.6 | $1,315.7 |
| CooperSurgical net sales by category: | ||||
| Office and surgical | $214.2 | $205.8 | $416.6 | $404.7 |
| Fertility | 143.8 | 126.9 | 270.4 | 246.6 |
| Total CooperSurgical net sales | 358.0 | 332.7 | 687.0 | 651.3 |
Item 1. Unaudited Financial Statements
FAQ
- What is The Cooper Companies, Inc.'s toric and multifocal — net sales?
- The Cooper Companies, Inc. (COO) reported toric and multifocal — net sales of $364.9M in Q1 2026.
- How has The Cooper Companies, Inc.'s toric and multifocal — net sales changed year-over-year?
- The Cooper Companies, Inc.'s toric and multifocal — net sales increased by 11.1% year-over-year, from $328.4M to $364.9M.
- What is the long-term trend for The Cooper Companies, Inc.'s toric and multifocal — net sales?
- Over 3 years (2022 to 2025), The Cooper Companies, Inc.'s toric and multifocal — net sales has grown at a 10.5% compound annual growth rate (CAGR), from $1B to $1.35B.
- What does toric and multifocal — net sales mean?
- This metric represents the total revenue generated from the sale of specialty contact lenses designed to correct astigmatism and presbyopia. These products typically command higher price points and represent a critical growth driver within the vision care portfolio due to their specialized nature. Tracking this revenue stream provides insight into the company's ability to capture market share in high-value, complex vision correction segments.
Ask your AI about The Cooper Companies, Inc.'s toric and multifocal — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude